Principal Financial Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.1M | Buy |
355,511
+59,840
| +20% | +$6.25M | 0.02% | 557 |
|
|
2025
Q1 | $34.5M | Buy |
295,671
+88,606
| +43% | +$10.3M | 0.02% | 554 |
|
|
2024
Q4 | $17.5M | Buy |
207,065
+203,672
| +6,003% | +$17.2M | 0.01% | 938 |
|
|
2024
Q3 | $305K | Sell |
3,393
-3,161
| -48% | -$284K | ﹤0.01% | 2026 |
|
|
2024
Q2 | $528K | Sell |
6,554
-3,219
| -33% | -$259K | ﹤0.01% | 1940 |
|
|
2024
Q1 | $780K | Buy |
9,773
+276
| +3% | +$22K | ﹤0.01% | 1903 |
|
|
2023
Q4 | $756K | Buy |
9,497
+120
| +1% | +$9.55K | ﹤0.01% | 1878 |
|
|
2023
Q3 | $655K | Sell |
9,377
-34,164
| -78% | -$2.39M | ﹤0.01% | 1902 |
|
|
2023
Q2 | $3.13M | Buy |
43,541
+33,821
| +348% | +$2.43M | ﹤0.01% | 1677 |
|
|
2023
Q1 | $600K | Sell |
9,720
-608
| -6% | -$37.5K | ﹤0.01% | 1932 |
|
|
2022
Q4 | $797K | Buy |
10,328
+1,694
| +20% | +$131K | ﹤0.01% | 1892 |
|
|
2022
Q3 | $385K | Sell |
8,634
-52
| -0.6% | -$2.32K | ﹤0.01% | 2016 |
|
|
2022
Q2 | $333K | Buy |
8,686
+3,598
| +71% | +$138K | ﹤0.01% | 2155 |
|
|
2022
Q1 | $211K | Buy |
+5,088
| New | +$211K | ﹤0.01% | 2325 |
|
|
2021
Q4 | – | Sell |
-7,418
| Closed | -$244K | – | 2541 |
|
|
2021
Q3 | $244K | Sell |
7,418
-5,646
| -43% | -$186K | ﹤0.01% | 2376 |
|
|
2021
Q2 | $882K | Sell |
13,064
-1,131
| -8% | -$76.4K | ﹤0.01% | 2071 |
|
|
2021
Q1 | $804K | Sell |
14,195
-522
| -4% | -$29.6K | ﹤0.01% | 2040 |
|
|
2020
Q4 | $1.2M | Buy |
14,717
+3,198
| +28% | +$261K | ﹤0.01% | 1905 |
|
|
2020
Q3 | $820K | Sell |
11,519
-527
| -4% | -$37.5K | ﹤0.01% | 1911 |
|
|
2020
Q2 | $991K | Buy |
12,046
+6,678
| +124% | +$549K | ﹤0.01% | 1832 |
|
|
2020
Q1 | $316K | Sell |
5,368
-2,157
| -29% | -$127K | ﹤0.01% | 1948 |
|
|
2019
Q4 | $777K | Buy |
+7,525
| New | +$777K | ﹤0.01% | 1872 |
|